Evidence map›Paper›PMID 41865339›Full record

Observational studyJournal of neurology2026

Clinical features of adolescent-onset functional motor disorders in tertiary movement disorders centers.

Christian Geroin, Tommaso Ercoli, Enrico Marcuzzo, Angela Sandri, Serena Camozzi, Domenico Maddaloni, Luigi Michele Romito, Roberto Eleopra, Lucia Tesolin, Serena Pellegrin and 36 more

Abstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors.

Christian Geroin *Department of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, P.le Scuro 10, 37134, Verona, Italy. christian.geroin@univr.it.ORCID http://orcid.org/0000-0001-6095-1930
Tommaso Ercoli *Neurology Unit, AOU Sassari, University of Sassari, Sassari, Italy.
Enrico MarcuzzoNeurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, P.le Scuro 10, 37134, Verona, Italy.
Angela SandriNeurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, P.le Scuro 10, 37134, Verona, Italy.
Serena CamozziNeurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, P.le Scuro 10, 37134, Verona, Italy.
Domenico MaddaloniNeurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, P.le Scuro 10, 37134, Verona, Italy.
Luigi Michele RomitoParkinson and Movement Disorders Unit, Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Roberto EleopraParkinson and Movement Disorders Unit, Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Lucia TesolinFND Outpatients Clinic, Neurology and Stroke Unit, General Hospital of Bolzano, Bolzano, Italy.
Serena PellegrinChild Neurology and Neurorehabilitation Unit, Department of Pediatrics, Provincial Hospital of Bolzano (SABES-ASDAA), Lehrkrankenhaus der Paracelsus Medizinischen Privatuniversität, Bolzano-Bozen, Italy.
Alessandra NicolettiDepartment G.F. Ingrassia, Section of Neurosciences, University of Catania, Catania, Italy.
Giovanni MostileDepartment G.F. Ingrassia, Section of Neurosciences, University of Catania, Catania, Italy.
Alessandro MagliozziNeurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Andrea PilottoNeurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Nicola ModugnoIRCCS Neuromed, Pozzilli, Italy.
Enrica OlivolaIRCCS Neuromed, Pozzilli, Italy.
Benedetta DemartiniAldo Ravelli Research Center for Neurotechnology and Experimental Brain Therapeutics, University of Milan, Milan, Italy.
Veronica NisticòAldo Ravelli Research Center for Neurotechnology and Experimental Brain Therapeutics, University of Milan, Milan, Italy.
Roberto ErroDepartment of Medicine, Surgery and Dentistry Scuola Medica Salernitana, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, Baronissi, Salerno, Italy.
Sofia CuocoDepartment of Medicine, Surgery and Dentistry Scuola Medica Salernitana, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, Baronissi, Salerno, Italy.
Alessandro TessitoreDepartment of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Rosa De MiccoDepartment of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Roberto CeravoloCentro Clinico Malattie NeuroDegenerative, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Eleonora Del PreteCentro Clinico Malattie NeuroDegenerative, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Carlo DallocchioS.C. Neurologia, Dipartimento di Area Medica Specialistica, ASST Pavia, Pavia, Italia.
Carla ArbasinoS.C. Neurologia, Dipartimento di Area Medica Specialistica, ASST Pavia, Pavia, Italia.
Marcello EspositoClinical Neurophysiology Unit, Cardarelli Hospital, Naples, Italy.
Trinchillo AssuntaDepartment of Medical, Motor and Wellness Sciences, University "Parthenope", Naples, Italy.
Francesco BonoNeurology Unit, Botulinum Toxin Therapy Center, Academic Hospital, A.O.U. "R. Dulbecco", Catanzaro, Italy.
Angelo PascarellaDepartment of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.
Martina PetraccaUOC Neurologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Paola ZinziUOC Neurologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Giovanni FabbriniIRCCS Neuromed, Pozzilli, Italy.
Gina FerrazzanoDepartment Human Neurosciences, Sapienza University of Rome, Rome, Italy.
Laura BonanniDepartment of Medicine and Aging Sciences, University G. d'Annunzio of Chieti-Pescara, Pescara, Italy.
Sara VaraneseClinica Neurologica Ospedale di Vasto, Chieti, Italy.
Alberto AlbaneseDepartment of Neurology, IRCCS Fondazione Istituto Neurologico C. Mondino, Pavia, Italy.
Paola PolverinoDepartment of Neurology, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Valentina BaglioniUnit of Child Neurology and Psychiatry, Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.
Giovanni DefazioDepartment of Translational Biomedicine and Neuroscience, Aldo Moro University of Bari, Bari, Italy.
Maurizio ZibettiDepartment of Neurosciences Rita Levi Montalcini, University of Turin, Turin, Italy.
Paolo ManganottiDepartment of Medical Surgical and Health Sciences Cattinara Hospital, University of Trieste, Trieste, Italy.
Paolo SollaNeurology Unit, AOU Sassari, University of Sassari, Sassari, Italy.
Giovanna Calandra-BuonauraIRCCS Istituto Delle Scienze Neurologiche di Bologna, Bologna, Italy.
Antonio PisaniDepartment Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Michele TinazziNeurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, P.le Scuro 10, 37134, Verona, Italy. michele.tinazzi@univr.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFunctional Motor Disorders (FMDs) represent a diagnostic and therapeutic challenge in pediatric neurology, particularly among adolescents. Their clinical presentation is common but often nonspecific, leading to frequent misdiagnoses and diagnostic delays. We aimed to characterize FMDs in adolescents and to examine the frequency of isolated and combined phenotypes and their associations with demographic and clinical variables.

methodsIn this observational study, data were obtained from the Italian Registry of FMDs, including patients with a clinically definite diagnosis of FMD consecutively enrolled at 25 Italian tertiary movement disorders centers.

resultsAmong 847 patients, 93 (10.9%) had adolescent-onset FMDs. Motor phenotypes did not differ significantly between adolescent- and adult-onset FMDs, with the exception of parkinsonism, which was observed only in the latter. Compared with adult-onset FMDs, adolescent-onset FMDs were associated with a longer disease duration, a higher number of medical consultations before diagnosis, and a higher frequency of functional seizures and infections, but with lower rates of insomnia, fatigue, and antipsychotic use. In multivariable analysis, adolescent-onset FMDs remained independently associated with a greater number of medical consultations (adjusted OR 1.07; 95% CI 1.02-1.13), the presence of functional seizures (adjusted OR 2.06; 95% CI 1.09-3.8), and with lower occurrence of insomnia (adjusted OR 0.49; 95% CI 0.27-0.92) and fatigue (adjusted OR 0.51; 95% CI 0.30-0.86). Pain was more likely to be associated with the combined FMDs phenotype.

conclusionsAdolescent-onset FMDs are common and are associated with several non-motor symptoms in tertiary movement disorders centers. Early and accurate diagnosis may help to reduce unnecessary investigations and inappropriate treatments.

Indexed as

Movement DisordersAdolescentAdultAge of OnsetChildFemaleHumansItalyMaleRegistriesTertiary Care CentersYoung AdultAdolescentsDiagnosisFunctional motor disordersFunctional neurological disorders

Identifiers

PMID41865339
PMCPMC13006462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.